ResMed Valuation

ResMed Inc -- USA Stock  

USD 88.58  0.15  0.17%

ResMed Inc holds recent Real Value of $83.30494999999999 per share. The prevailing price of the company is $88.58. At this time the company appears to be over valued. Macroaxis determines value of ResMed Inc from analyzing the company fundamentals such as Shares Outstanding of 141.9M, Operating Margin of 22.36% and Return On Equity of 18.43% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.

Valuation Drivers Correlation

Selected ResMed Inc Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Market Capitalization    
 Time Horizon     30 Days    Login   to change
ResMed Inc is rated third in price to sales category among related companies. It is rated fifth in beta category among related companies totaling about  0.13  of Beta per Price to Sales. The ratio of Price to Sales to Beta for ResMed Inc is roughly  7.45 
Over Valued
January 18, 2018
88.58
Market Value
Downside upside
83.3
Real Value
Target Price Odds
 Above  Below  
97.44
Upside
Upside upside
ResMed is not too risky asset. Calculation of real value of ResMed Inc is based on 1 month time horizon. Increasing ResMed Inc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Recommendations

ResMed Analyst Recommendations
Target PriceAdvice# of Analysts
63.18Hold9Odds
ResMed Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
ResMed Analyst Advice  

Tax Efficiency

ResMed Inc Tax Efficiency History

Tax Efficiency

Market Capitalization

ResMed Market Capitalization Analysis
ResMed Inc is rated fifth in market capitalization category among related companies. Market capitalization of Medical Equipment industry is at this time estimated at about 107.54 Billion. ResMed retains roughly 12.35 Billion in market capitalization claiming about 11% of all equities under Medical Equipment industry.
Capitalization  Total debt  Workforce  Valuation  Revenue

Revenue

ResMed Inc Revenue
Based on latest financial disclosure ResMed Inc reported 2.12 B of revenue. This is 67.38% lower than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Revenue for all stocks is 78.47% higher than the company.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.